Asian Pacific Journal of Cancer Prevention

  • 제16권13호
  • /
  • Pages.5471-5476
  • /
  • 2015
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

High Efficiency Apoptosis Induction in Breast Cancer Cell Lines by MLN4924/2DG Co-Treatment

  • Oladghaffari, Maryam (Cellular & Molecular Biology Research Center, Medical Physics Department, Faculty of Medicine, Babol University of Medical Sciences) ;
  • Islamian, Jalil Pirayesh (Department of Medical Physics, Faculty of Medicine, Tabriz University of Medical Sciences) ;
  • Baradaran, Behzad (Immunology Research Center) ;
  • Monfared, Ali Shabestani (Cellular & Molecular Biology Research Center, Medical Physics Department, Faculty of Medicine, Babol University of Medical Sciences) ;
  • Farajollahi, Alireza (Department of Medical Physics, Faculty of Medicine, Tabriz University of Medical Sciences) ;
  • Shanehbandi, Dariush (Immunology Research Center) ;
  • Mohammadi, Mohsen (Department of Medical Physics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences)
  • 발행 : 2015.08.03
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

2-deoxy-D-Glucose (2DG) causes cytotoxicity in cancer cells by disrupting thiol metabolism. It is an effective component in therapeutic strategies. It targets the metabolism of cancer cells with glycolysis inhibitory activity. On the other hand, MLN4924, a newly discovered investigational small molecule inhibitor of NAE (NEDD8 activating enzyme), inactivates SCF E3 ligase and causes accumulation of its substrates which triggers apoptosis. Combination of these components might provide a more efficient approach to treatment. In this research, 2DG and MLN4924 were co-applied to breast cancer cells (MCF-7 and SKBR-3) and cytotoxic and apoptotic activity were evaluated the by Micro culture tetrazolium test (MTT), TUNEL and ELISA methods. Caspase3 and Bcl2 genes expression were evaluated by real time Q-PCR methods. The results showed that MLN4924 and MLN4924/2DG dose-dependently suppressed the proliferation of MCF7 and SKBR-3 cells. Cell survival of breast cancer cells exposed to the combination of 2DG/MLN4924 was decreased significantly compared to controls (p<0.05), while 2DG and MLN4924 alone had less pronounced effects on the cells. The obtained results suggest that 2DG/MLN4924 is much more efficient in breast cancer cell lines with enhanced cytotoxicity via inducing a apoptosis cell signaling gene, caspase-3.

키워드

참고문헌

  1. Aft R, Zhang F, Gius D (2002). Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. British J Cancer, 87, 805-12. https://doi.org/10.1038/sj.bjc.6600547
  2. Aghaee F, Pirayesh Islamian J, Baradaran B (2012). Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer, 15, 141-7. https://doi.org/10.4048/jbc.2012.15.2.141
  3. Ahmad I, Mustafa E, Mustafa N, et al (2010). 2DG enhances the susceptibility of breast cancer cells to doxorubicin. Open Life Sci, 5, 739-48.
  4. Basler M, Lauer C, Beck U, et al (2009). The proteasome inhibitor bortezomib enhances the susceptibility to viral infection. J Immunol, 183, 6145-50. https://doi.org/10.4049/jimmunol.0901596
  5. Ben Sahra I, Laurent K, Giuliano S, et al (2010). Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res, 70, 2465-75. https://doi.org/10.1158/0008-5472.CAN-09-2782
  6. DiPaola RS, Dvorzhinski D, Thalasila A, et al (2008). Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate, 68, 1743-52. https://doi.org/10.1002/pros.20837
  7. Duan S, Skaar JR, Kuchay S, et al (2011). mTOR generates an auto-amplification loop by triggering the ${\beta}$TrCP-and CK1${\alpha}$-dependent degradation of DEPTOR. Molecular cell, 44, 317-24. https://doi.org/10.1016/j.molcel.2011.09.005
  8. Dwarakanath BS (2009). Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro. J Cancer Res Ther, 5, 27-31. https://doi.org/10.4103/0973-1482.55137
  9. Edelmann MJ, Nicholson B, Kessler BM (2011). Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases. Expert Rev Mol Med, 13, 35. https://doi.org/10.1017/S1462399411002031
  10. Emanuele MJ, Elia AE, Xu Q, et al (2011). Global identification of modular cullin-RING ligase substrates. Cell, 147, 459-74. https://doi.org/10.1016/j.cell.2011.09.019
  11. Heminger K, Jain V, Kadakia M, et al (2006). Altered gene expression induced by ionizing radiation and glycolytic inhibitor 2-deoxy-glucose in a human glioma cell line: implications for radio sensitization. Cancer Biol Ther, 5, 815-23. https://doi.org/10.4161/cbt.5.7.2812
  12. Jia L, Li H, Sun Y (2011). Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression. Neoplasia (New York, NY), 13, 561. https://doi.org/10.1593/neo.11420
  13. Kern KA, Norton JA (1987). Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-Dglucose. Surgery, 102, 380-5.
  14. Lee YJ, Galoforo SS, Berns CM, et al (1997). Glucose deprivation-induced cytotoxicity in drug resistant human breast carcinoma MCF-7/ADR cells: role of c-myc and bcl-2 in apoptotic cell death. J Cell Sci, 110, 681-6.
  15. Liao H, Liu XJ, Blank JL, et al (2011). Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924. Mol Cell Proteomics, 10, 111.
  16. Lin H-K, Chen Z, Wang G, et al (2010a). Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature, 464, 374-9. https://doi.org/10.1038/nature08815
  17. Lin JJ, Milhollen MA, Smith PG, et al (2010b). NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res, 70, 10310-20. https://doi.org/10.1158/0008-5472.CAN-10-2062
  18. Lin X, Zhang F, Bradbury CM, et al (2003). 2-Deoxy-D-glucoseinduced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res, 63, 3413-7.
  19. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the $2^{-{\Delta}{\Delta}CT}$ method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262
  20. Luo Z, Pan Y, Jeong LS, et al (2012a). Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells. Autophagy, 8, 1677-9. https://doi.org/10.4161/auto.21484
  21. Luo Z, Yu G, Lee HW, et al (2012b). The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. Cancer Res, 72, 3360-71. https://doi.org/10.1158/0008-5472.CAN-12-0388
  22. Mackintosh C, Garcia-Dominguez DJ, Ordonez JL, et al (2013). WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells. Oncogene, 32, 1441-51. https://doi.org/10.1038/onc.2012.153
  23. Milhollen MA, Narayanan U, Soucy TA, et al (2011). Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover. Cancer Res, 71, 3042-51. https://doi.org/10.1158/0008-5472.CAN-10-2122
  24. Milhollen MA, Traore T, Adams-Duffy J, et al (2010). MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. Blood, 116, 1515-23. https://doi.org/10.1182/blood-2010-03-272567
  25. Nawrocki ST, Griffin P, Kelly KR, et al (2012). MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy. Expert opinion investigational drugs, 21, 1563-73. https://doi.org/10.1517/13543784.2012.707192
  26. Simons AL, Mattson DM, Dornfeld K, et al (2009). Glucose deprivation-induced metabolic oxidative stress and cancer therapy. J Cancer Res Ther, 5, 2. https://doi.org/10.4103/0973-1482.55133
  27. Soucy TA, Smith PG, Milhollen MA, et al (2009). An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature, 458, 732-6. https://doi.org/10.1038/nature07884
  28. Subarnas A, Diantini A, Abdulah R, et al (2012). Antiproliferative activity of primates-consumed plants against MCF-7 human breast cancer cell lines. E3 J Med Res, 1, 38-43.
  29. Sun Y, Li H (2013). Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase. Protein cell, 4, 103-16. https://doi.org/10.1007/s13238-012-2105-7
  30. Swords RT, Kelly KR, Smith PG, et al (2010). Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. Blood, 115, 3796-800. https://doi.org/10.1182/blood-2009-11-254862
  31. Tan M, Li Y, Yang R, et al (2011). Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid. PLoS One, 6, 27726. https://doi.org/10.1371/journal.pone.0027726
  32. Wei D, Li H, Yu J, et al (2012). Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer Res, 72, 282-93. https://doi.org/10.1158/0008-5472.CAN-11-2866
  33. Yang D, Tan M, Wang G, et al (2012a). The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme. PLoS One, 7, 34079. https://doi.org/10.1371/journal.pone.0034079
  34. Yang D, Zhao Y, Liu J, et al (2012b). Protective autophagy induced by RBX1/ROC1 knockdown or CRL inactivation via modulating the DEPTOR-MTOR axis. Autophagy, 8, 1856-8. https://doi.org/10.4161/auto.22024
  35. Yao W, Wu J, Yu G, et al (2014). Suppression of tumor angiogenesis by targeting the protein neddylation pathway. Cell Death Disease, 5, 1059. https://doi.org/10.1038/cddis.2014.21
  36. Zhang F, Aft RL (2009). Chemosensitizing and cytotoxic effects of 2-deoxy-D-glucose on breast cancer cells. J Cancer Res Ther, 5, 41-3.
  37. Zhao Y, Xiong X, Jia L, et al (2012). Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis. Cell Death Disease, 3, 386. https://doi.org/10.1038/cddis.2012.125

피인용 문헌

  1. Golgi apparatus dis- and reorganizations studied with the aid of 2-deoxy-d-glucose and visualized by 3D-electron tomography vol.147, pp.4, 2017, https://doi.org/10.1007/s00418-016-1515-7
  2. Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML vol.131, pp.13, 2018, https://doi.org/10.1182/blood-2017-09-805895
  3. Moving Breast Cancer Therapy up a Notch vol.8, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2018.00518